Clinical genetic testing for BRCA1/2 gene mutations is currently available as a service on the NHS in the UK to individuals with a 10% or greater chance of carrying a BRCA1/2 mutation [3] including those with high grade non-mucinous ovarian cancer, or those with a strong family history of breast and/or ovarian cancer. The gene discussed is BRCA1; the disease is ovarian cancer.